{"count": 103, "results": [{"_id": "39552144", "pmid": 39552144, "title": "Platelet storage failure-Metformin as causative agent.", "journal": "Transfusion", "authors": ["Dumont LJ", "Kelly K", "Nemkov T", "Leite C", "Gresens CJ", "Stanley C", "D'Alessandro A", "Vassallo RR"], "date": "2024-11-17T00:00:00Z", "doi": "10.1111/trf.18063", "meta_date_publication": "2024 Nov 17", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50274.555, "text_hl": "@<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@Platelet storage failure@@@-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as causative agent.", "citations": {"NLM": "Dumont LJ, Kelly K, Nemkov T, Leite C, Gresens CJ, Stanley C, D'Alessandro A, Vassallo RR. Platelet storage failure-Metformin as causative agent. Transfusion. 2024 Nov 17;():. PMID: 39552144", "BibTeX": "@article{39552144, title={Platelet storage failure-Metformin as causative agent.}, author={Dumont LJ and Kelly K and Nemkov T and Leite C and Gresens CJ and Stanley C and D'Alessandro A and Vassallo RR}, journal={Transfusion}}"}}, {"_id": "35831909", "pmid": 35831909, "pmcid": "PMC9281002", "title": "Utility of support vector machine and decision tree to identify the prognosis of metformin poisoning in the United States: analysis of National Poisoning Data System", "journal": "BMC Pharmacol Toxicol", "authors": ["Mehrpour O", "Saeedi F", "Hoyte C", "Goss F", "Shirazi FM"], "date": "2022-07-13T00:00:00Z", "doi": "10.1186/s40360-022-00588-0", "meta_date_publication": "2022 Jul 13", "meta_volume": "23", "meta_issue": "1", "meta_pages": "49", "score": 50267.27, "text_hl": "In line with other studies, we also showed that @DISEASE_Acidosis @DISEASE_MESH:D000138 @@@acidosis@@@, @DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@hypoglycemia@@@, @DISEASE_Water_Electrolyte_Imbalance @DISEASE_MESH:D014883 @@@electrolyte abnormality@@@, @DISEASE_Hypotension @DISEASE_MESH:D007022 @@@hypotension@@@, elevated anion gap, elevated @CHEMICAL_Creatinine @CHEMICAL_MESH:D003404 @@@creatinine@@@, @DISEASE_Tachycardia @DISEASE_MESH:D013610 @@@tachycardia@@@, @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@renal failure@@@, age, and unintentional exposure to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ are the determinants of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ @DISEASE_Poisoning @DISEASE_MESH:D011041 @@@poisoning@@@ prognosis. ", "citations": {"NLM": "Mehrpour O, Saeedi F, Hoyte C, Goss F, Shirazi FM. Utility of support vector machine and decision tree to identify the prognosis of metformin poisoning in the United States: analysis of National Poisoning Data System BMC Pharmacol Toxicol. 2022 Jul 13;23(1):49. PMID: 35831909", "BibTeX": "@article{35831909, title={Utility of support vector machine and decision tree to identify the prognosis of metformin poisoning in the United States: analysis of National Poisoning Data System}, author={Mehrpour O and Saeedi F and Hoyte C and Goss F and Shirazi FM}, journal={BMC Pharmacol Toxicol}, volume={23}, number={1}, pages={49}}"}}, {"_id": "37948503", "pmid": 37948503, "title": "Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A Pharmacovigilance-Pharmacokinetic Appraisal.", "journal": "Diabetes Care", "authors": ["Xie W", "Li J", "Kong C", "Luo W", "Zheng J", "Zhou Y"], "date": "2023-11-10T00:00:00Z", "doi": "10.2337/dc23-1344", "meta_date_publication": "2023 Nov 10", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50256.812, "text_hl": "RESULTS: Following the 2016 Food and Drug Administration @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ approval for mild-to-moderate @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@RF@@@, the percentage of patients with @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@RF@@@ reporting @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@LA@@@ associated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ combined with H2RI increased. ", "citations": {"NLM": "Xie W, Li J, Kong C, Luo W, Zheng J, Zhou Y. Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A Pharmacovigilance-Pharmacokinetic Appraisal. Diabetes Care. 2023 Nov 10;():. PMID: 37948503", "BibTeX": "@article{37948503, title={Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A Pharmacovigilance-Pharmacokinetic Appraisal.}, author={Xie W and Li J and Kong C and Luo W and Zheng J and Zhou Y}, journal={Diabetes Care}}"}}, {"_id": "35186553", "pmid": 35186553, "pmcid": "PMC8846262", "title": "A Comparative Study of Acidosis in Diabetic Advanced Chronic Kidney Disease Patients on and off Metformin", "journal": "Cureus", "authors": ["Qureshi R", "Nasir K", "Dhrolia M", "Ahmad A"], "date": "2022-01-16T00:00:00Z", "doi": "10.7759/cureus.21291", "meta_date_publication": "2022 Jan", "meta_volume": "14", "meta_issue": "1", "meta_pages": "e21291", "score": 50255.72, "text_hl": "@DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@MALA@@@ occurs in @SPECIES_9606 @@@patients@@@ taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ who have @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@renal failure@@@. ", "citations": {"NLM": "Qureshi R, Nasir K, Dhrolia M, Ahmad A. A Comparative Study of Acidosis in Diabetic Advanced Chronic Kidney Disease Patients on and off Metformin Cureus. 2022 Jan;14(1):e21291. PMID: 35186553", "BibTeX": "@article{35186553, title={A Comparative Study of Acidosis in Diabetic Advanced Chronic Kidney Disease Patients on and off Metformin}, author={Qureshi R and Nasir K and Dhrolia M and Ahmad A}, journal={Cureus}, volume={14}, number={1}, pages={e21291}}"}}, {"_id": "33290248", "pmid": 33290248, "title": "Postintervention Effects of Varying Treatment Arms on Glycemic Failure and beta-Cell Function in the TODAY Trial.", "journal": "Diabetes Care", "authors": ["TODAY Study Group"], "date": "2021-01-01T00:00:00Z", "doi": "10.2337/dc20-0622", "meta_date_publication": "2021 Jan", "meta_volume": "44", "meta_issue": "1", "meta_pages": "75-80", "score": 50255.688, "text_hl": "OBJECTIVE: The Treatment Options for @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 Diabetes@@@ in Adolescents and Youth (TODAY) trial demonstrated that @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@glycemic failure@@@ rates were significantly lower in youth randomized to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ plus @CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@ treatment than in youth randomized to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ alone or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ plus intensive lifestyle intervention. ", "citations": {"NLM": "TODAY Study Group. Postintervention Effects of Varying Treatment Arms on Glycemic Failure and beta-Cell Function in the TODAY Trial. Diabetes Care. 2021 Jan;44(1):75-80. PMID: 33290248", "BibTeX": "@article{33290248, title={Postintervention Effects of Varying Treatment Arms on Glycemic Failure and beta-Cell Function in the TODAY Trial.}, author={TODAY Study Group}, journal={Diabetes Care}, volume={44}, number={1}, pages={75-80}}"}}, {"_id": "33562458", "pmid": 33562458, "pmcid": "PMC7915435", "title": "The Current and Potential Therapeutic Use of Metformin:The Good Old Drug", "journal": "Pharmaceuticals (Basel)", "authors": ["Drzewoski J", "Hanefeld M"], "date": "2021-02-05T00:00:00Z", "doi": "10.3390/ph14020122", "meta_date_publication": "2021 Feb 5", "meta_volume": "14", "meta_issue": "2", "meta_pages": "", "score": 50255.035, "text_hl": "This paper presents some arguments supporting the initiation of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @SPECIES_9606 @@@patients@@@ with newly diagnosed @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@, especially those without cardiovascular risk factors or without established @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular disease@@@ or advanced @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@kidney insufficiency@@@ at the time of new guidelines favoring new drugs with pleotropic effects complimentary to @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ control. ", "citations": {"NLM": "Drzewoski J, Hanefeld M. The Current and Potential Therapeutic Use of Metformin:The Good Old Drug Pharmaceuticals (Basel). 2021 Feb 5;14(2):. PMID: 33562458", "BibTeX": "@article{33562458, title={The Current and Potential Therapeutic Use of Metformin:The Good Old Drug}, author={Drzewoski J and Hanefeld M}, journal={Pharmaceuticals (Basel)}, volume={14}, number={2}}"}}, {"_id": "32364526", "pmid": 32364526, "pmcid": "PMC7244070", "title": "Metformin: the updated protective property in kidney disease", "journal": "Aging (Albany NY)", "authors": ["Pan Q", "Lu X", "Zhao C", "Liao S", "Chen X", "Guo F", "Yang C", "Liu HF"], "date": "2020-05-01T00:00:00Z", "doi": "10.18632/aging.103095", "meta_date_publication": "2020 May 1", "meta_volume": "12", "meta_issue": "9", "meta_pages": "8742-8759", "score": 50254.477, "text_hl": "Furthermore, the United States Food and Drug Administration declared @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is safe for @SPECIES_9606 @@@patients@@@ with mild or moderate @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@kidney impairment@@@ in 2016, assuaging some conservative attitudes about @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ management in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@renal insufficiency@@@ and broadening the scope of research on the renal protective effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Pan Q, Lu X, Zhao C, Liao S, Chen X, Guo F, Yang C, Liu HF. Metformin: the updated protective property in kidney disease Aging (Albany NY). 2020 May 1;12(9):8742-8759. PMID: 32364526", "BibTeX": "@article{32364526, title={Metformin: the updated protective property in kidney disease}, author={Pan Q and Lu X and Zhao C and Liao S and Chen X and Guo F and Yang C and Liu HF}, journal={Aging (Albany NY)}, volume={12}, number={9}, pages={8742-8759}}"}}, {"_id": "37424987", "pmid": 37424987, "title": "Metformin-Associated Lactic Acidosis: A Case Report.", "journal": "HCA Healthc J Med", "authors": ["Santoli J", "Aldakkour JL", "Tohidi H", "Lin Y"], "date": "2023-04-28T00:00:00Z", "doi": "10.36518/2689-0216.1508", "meta_date_publication": "2023", "meta_volume": "4", "meta_issue": "2", "meta_pages": "215-218", "score": 50251.4, "text_hl": "...Introduction: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is considered a first-line therapy for patients with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ secondary to its cost efficiency, minimal side effects, and marked improvement in one's hemoglobin A1c; however, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is avoided in patients with @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@renal insufficiency@@@ out of concern for drug accumulation and @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@. ", "citations": {"NLM": "Santoli J, Aldakkour JL, Tohidi H, Lin Y. Metformin-Associated Lactic Acidosis: A Case Report. HCA Healthc J Med. 2023;4(2):215-218. PMID: 37424987", "BibTeX": "@article{37424987, title={Metformin-Associated Lactic Acidosis: A Case Report.}, author={Santoli J and Aldakkour JL and Tohidi H and Lin Y}, journal={HCA Healthc J Med}, volume={4}, number={2}, pages={215-218}}"}}, {"_id": "34437006", "pmid": 34437006, "pmcid": "PMC8143825", "title": "Reversible Total Vision Loss Caused by Severe Metformin-associated Lactic Acidosis: A Case Report", "journal": "Clin Pract Cases Emerg Med", "authors": ["Koons A", "Amaducci AM", "Katz KD"], "date": "2021-05-01T00:00:00Z", "doi": "10.5811/cpcem.2021.3.51141", "meta_date_publication": "2021 May", "meta_volume": "5", "meta_issue": "2", "meta_pages": "206-209", "score": 50247.996, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-associated @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@ (@DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@MALA@@@) carries a high mortality and can occur in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@renal failure@@@ from drug bioaccumulation. ", "citations": {"NLM": "Koons A, Amaducci AM, Katz KD. Reversible Total Vision Loss Caused by Severe Metformin-associated Lactic Acidosis: A Case Report Clin Pract Cases Emerg Med. 2021 May;5(2):206-209. PMID: 34437006", "BibTeX": "@article{34437006, title={Reversible Total Vision Loss Caused by Severe Metformin-associated Lactic Acidosis: A Case Report}, author={Koons A and Amaducci AM and Katz KD}, journal={Clin Pract Cases Emerg Med}, volume={5}, number={2}, pages={206-209}}"}}, {"_id": "35274817", "pmid": 35274817, "pmcid": "PMC8915386", "title": "Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin", "journal": "Physiol Rep", "authors": ["Theurey P", "Vial G", "Fontaine E", "Monternier PA", "Fouqueray P", "Bolze S", "Moller DE", "Hallakou-Bozec S"], "date": "2022-03-01T00:00:00Z", "doi": "10.14814/phy2.15151", "meta_date_publication": "2022 Mar", "meta_volume": "10", "meta_issue": "5", "meta_pages": "e15151", "score": 50247.65, "text_hl": "@SPECIES_10116 @@@Rats@@@ with @CHEMICAL_Gentamicins @CHEMICAL_MESH:D005839 @@@gentamycin@@@-induced @<m>DISEASE_Renal_Insufficiency</m> @DISEASE_MESH:D051437 @@@renal insufficiency@@@ received @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ or @CHEMICAL_imeglimin @CHEMICAL_MESH:C575881 @@@Imeglimin@@@ (50-100 mg/kg/h), only @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ increased lactatemia and @CHEMICAL_Hydrogen @CHEMICAL_MESH:D006859 @@@H+@@@ concentrations with mortality at higher doses. ", "citations": {"NLM": "Theurey P, Vial G, Fontaine E, Monternier PA, Fouqueray P, Bolze S, Moller DE, Hallakou-Bozec S. Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin Physiol Rep. 2022 Mar;10(5):e15151. PMID: 35274817", "BibTeX": "@article{35274817, title={Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin}, author={Theurey P and Vial G and Fontaine E and Monternier PA and Fouqueray P and Bolze S and Moller DE and Hallakou-Bozec S}, journal={Physiol Rep}, volume={10}, number={5}, pages={e15151}}"}}]}